Anest. intenziv. Med. 2012;23(3):133-136

Mechanical circulatory support devicesUpdate in Intensive Care Medicine

Říha Hynek1,2,*, Kramář Petr1, Syrovátka Petr1, Rzyman Robert1, Říhová Leona1, Netuka Ivan3, Malý Jiří3, Kettner Jiří4, Pirk Jan3, Kotulák Tomáš1,2
1 Klinika anesteziologie a resuscitace, Kardiocentrum IKEM, Praha
2 Klinika anesteziologie, resuscitace a intenzivní medicíny, 1. LF UK, Praha
3 Klinika kardiovaskulární chirurgie, Kardiocentrum IKEM, Praha
4 Klinika kardiologie, Kardiocentrum IKEM, Praha

Mechanical circulatory support devices (MCS) constitute an important part of acute and chronic heart failure therapy. The principal objective of the MCS implantation is to restore adequate circulation including optimal oxygen delivery to the tissues with subsequent normalization of tissue functions. The most frequent indications for MCS implantation are bridge-to-heart transplantation, and bridge-to-recovery after various types of myocardial injury (e.g., acute myocardial infarction, myocarditis, extensive cardiac surgical procedures). In the Czech Republic, the most frequently used MCS devices are the intraaortic balloon pump, ventricular assist devices (VAD) and extracorporeal membrane oxygenation (ECMO).

Keywords: mechanical circulatory support; ventricular assist devices; extracorporeal membrane oxygenation; heart failure; echocardiography; anticoagulation therapy

Received: April 30, 2012; Accepted: May 31, 2012; Published: June 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Říha H, Kramář P, Syrovátka P, Rzyman R, Říhová L, Netuka I, et al.. Mechanical circulatory support devices. Anest. intenziv. Med. 2012;23(3):133-136.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Augoustides, J. G., Říha, H. Recent progress in heart failure treatment and heart transplantation. J. Cardiothorac. Vasc. Anesth., 2009, 23, 5, p. 738-748. Go to original source... Go to PubMed...
    2. Březina, A., Říha, H., Mašín, J. Současné možnosti mechanické podpory cirkulace. Anest. intenziv. Med., 2006, 17, 1, s. 38-44.
    3. Netuka, I., Malý, J., Říha, H. et al. Přínos dlouhodobé pulzatilní mechanické srdeční podpory u multiorgánově selhávajících pacientů v terminálním srdečním selhání. Čas. Lék. česk., 2011, 150, 1, s. 44-48.
    4. Říha, H., Netuka, I., Kotulák, T. et al. Dysfunkce pravé komory po implantaci levostranné mechanické srdeční podpory. Vnitř. Lék., 2010, 56, 1, s. 30-36.
    5. Bělohlávek, J., Rohn, V., Jansa, P. et al. Veno-arterial ECMO in severe acute right ventricular failure with pulmonary obstructive hemodynamic pattern. J. Invasive Cardiol., 2010, 22, 8, p. 365-369. Go to PubMed...
    6. Kettner, J., Dorazilová, Z., Netuka, I. et al. Is severe pulmonary hypertension a contraindication for orthotopic heart transplantation? Not any more. Physiol. Res., 2011, 60, 5, p. 769-775. Go to original source... Go to PubMed...
    7. Dorazilová, Z., Kettner, J., Netuka, I. et al. Levostranná mechanická srdeční podpora v léčbě závažné plicní hypertenze u kandidátů srdeční transplantace v IKEM. Cor Vasa, 2011, 53, 1-2, s. 48-54.
    8. Krüger, A., Ošťádal, P., Kmoníček, P. et al. Profylaktické použití mimotělní podpory oběhu s membránovým oxygenátorem u rizikové perkutánní koronární intervence. Cor Vasa, 2010, 52, 3, s. 141-144. Go to original source...
    9. Bělohlávek, J., Rohn, V., Tošovský, J. et al. A review of a newly established ECMO program in a university affiliated cardiac center. J. Cardiovasc. Surg. (Torino), 2011, 52, 3, p. 445-451. Go to PubMed...
    10. Bělohlávek, J., Rohn, V., Kunstýř, J. et al. Profil pacientů léčených extrakorporální membránovou oxygenací (ECMO). Interv. akut. Kardiol., 2010, 9, 3, s. 121-128.
    11. Netuka, I., Malý, J., Szarszoi, O. Mechanické srdeční podpory v terapii terminálního srdečního selhání. Cor Vasa, 2008, 50, 5, s. 207-214. Go to original source...
    12. Březina, A., Říha, H. Kardiogenní šok a současné možnosti jeho léčby. Anest. intenziv. Med., 2007, 18, 5, s. 301-304.
    13. Stone, M. E. Current status of mechanical circulatory assistance. Semin. Cardiothorac. Vasc. Anesth., 2007, 11, 3, p. 185-204. Go to original source... Go to PubMed...
    14. Kettner, J., Pirk, J., Netuka, I. et al. Použití mechanické srdeční podpory - první zkušenosti v České republice. Čas. Lék. česk., 2005, 144, 1, s. 38-42.
    15. Netuka, I., Malý, J., Szárszoi, O. et al. Technika implantace a zkušenosti s dočasnou mechanickou srdeční podporou při selhání pravé komory. Rozhl. Chir., 2011, 90, 2, s. 88-94. Go to PubMed...
    16. Říha, H., Kotulák, T., Netuka, I. et al. Intenzivní péče o pacienty po implantaci mechanických srdečních podpor. Cor Vasa, 2011, 53, 1-2, s. 94-98. Go to original source...
    17. Gariboldi, V., Grisoli, D., Tarmiz, A. et al. Mobile extracorporeal membrane oxygenation unit expands cardiac assist surgical programs. Ann. Thorac. Surg., 2010, 90, 5, p. 1548-1552. Go to original source... Go to PubMed...
    18. Al-Hiti, H., Melenovský, V., Syrovátka, P. et al. Sildenafil is more selective pulmonary vasodilator than prostaglandin E1 in patients with pulmonary hypertension due to heart failure. Physiol. Res., 2011, 60, 2, p. 303-308. Go to original source... Go to PubMed...
    19. Říha, H., Říhová, L., Pinďák, M. et al. Metylénová modř v léčbě vazoplegického syndromu po kardiochirurgické operaci. Čas. Lék. česk., 2006, 145, 4, s. 322-324.
    20. Guirgis, M., Kumar, K., Menkis, A. H. et al. Minimally invasive left-heart decompression during venoarterial extracorporeal membrane oxygenation: an alternative to a percutaneous approach. Interact. Cardiovasc. Thorac. Surg., 2010, 10, 5, p. 672-674. Go to original source... Go to PubMed...
    21. Chumnanvej, S., Wood, M. J., MacGillivray, T. E. et al. Perioperative echocardiographic examination for ventricular assist device implantation. Anesth. Analg., 2007, 105, 3, p. 583-601. Go to original source... Go to PubMed...
    22. Marek, T., Dorazilová, Z., Straka, F. et al. Role echokardiografie v péči o pacienty s mechanickou srdeční podporou HeartMate II. Cor Vasa, 2011, 53, 1-2, s. 55-59.
    23. Myers, T. J., Bolmers, M., Gregoric, I. D. et al. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J. Heart Lung Transplant., 2009, 28, 5, p. 423-427. Go to original source... Go to PubMed...
    24. Říha, H., Netuka, I., Kotulák, T. et al. Anesthesia management of a patient with a ventricular assist device for noncardiac surgery. Semin. Cardiothorac. Vasc. Anesth., 2010, 14, 1, s. 29-31. Go to original source... Go to PubMed...
    25. John, R., Kamdar, F., Liao, K. et al. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J. Thorac. Cardiovasc. Surg., 2008, 136, 5, p. 1318-1323. Go to original source... Go to PubMed...
    26. Slaughter, M. S., Naka, Y., John, R. et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. J. Heart Lung Transplant., 2010, 29, 6, s. 616-624. Go to original source... Go to PubMed...
    27. Heilmann, C., Geisen, U., Benk, C. et al. Haemolysis in patients with ventricular assist devices: major differences between systems. Eur. J. Cardiothorac. Surg., 2009, 36, 3, s. 580-584. Go to original source... Go to PubMed...
    28. Aziz, T. A., Singh, G., Popjes, E. et al. Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. J. Heart Lung Transplant., 2010, 29, 1, s. 66-71. Go to original source... Go to PubMed...
    29. Mohri, H. Acquired von Willebrand syndrome: features and management. Am. J. Hematol., 2006, 81, 8, p. 616-623. Go to original source... Go to PubMed...
    30. Crow, S., Chen, D., Milano, C. et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann. Thorac. Surg., 2010, 90, 4, p. 1263-1269; discussion 1269. Go to original source... Go to PubMed...
    31. Heilmann, C., Geisen, U., Beyersdorf, F. et al. Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Inten. Care Med., 2012, 38, 1, p. 62-68. Go to original source... Go to PubMed...
    32. Koster, A., Huebler, S., Potapov, E. et al. Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients. Ann. Thorac. Surg., 2007, 83, 1, p. 72-76. Go to original source... Go to PubMed...
    33. Barzaghi, N., Locatelli, A., Ranucci, M. Ventricular assist device implantation and the risk for heparin-induced thrombocytopenia. Ann. Thorac. Surg., 2008, 85, 1, p. 360-361. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.